Administration of G-CSF from day +6 post-allogeneic hematopoietic stem cell transplantation in children and adolescents accelerates neutrophil engraftment but does not appear to have an impact on cost savings

MLA

Ciara O’Rafferty, et al. “Administration of G-CSF from Day +6 Post-Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents Accelerates Neutrophil Engraftment but Does Not Appear to Have an Impact on Cost Savings.” Pediatric Transplantation, vol. 20, Feb. 2016, pp. 432–37. EBSCOhost, https://doi.org/10.1111/petr.12670.

APA

Ciara O’Rafferty, Mairead O’Brien, Hillary Robinson, Elaine Smyth, Aengus O’Marcaigh, Paul Lynam, Owen P. Smith, & Sinead Keane. (2016). Administration of G-CSF from day +6 post-allogeneic hematopoietic stem cell transplantation in children and adolescents accelerates neutrophil engraftment but does not appear to have an impact on cost savings. Pediatric Transplantation, 20, 432–437. https://doi.org/10.1111/petr.12670

Chicago

Ciara O’Rafferty, Mairead O’Brien, Hillary Robinson, Elaine Smyth, Aengus O’Marcaigh, Paul Lynam, Owen P. Smith, and Sinead Keane. 2016. “Administration of G-CSF from Day +6 Post-Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents Accelerates Neutrophil Engraftment but Does Not Appear to Have an Impact on Cost Savings.” Pediatric Transplantation 20 (February): 432–37. doi:10.1111/petr.12670.